<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The efficacy of endoscopic biopsy surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in reducing mortality from <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> has not been confirmed </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To investigate the impact of endoscopic biopsy surveillance on pathological stage and clinical outcome of Barrett's <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A clinicopathological comparison was made between patients who initially presented with oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 54), and those in whom the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> had been detected during surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (n = 16) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The surveyed patients were known to have <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> for a median period of 42 months (range 6-144 months) </plain></SENT>
<SENT sid="4" pm="."><plain>Prior to the detection of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> or high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 13 to 16 patients (81%) were previously found to have low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Surgical pathology showed that surveyed patients had significantly earlier stages than non-surveyed patients (p = 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Only one surveyed patient (6%) versus 34 non-surveyed patients (63%) had nodal involvement (p = 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Two year survival was 85.9% for surveyed patients and 43.3% for non-surveyed patients (p = 0.0029) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The temporal course of histological progression in our surveyed patients supports the theory that <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> develops through stages of increasing severity of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Endoscopic biopsy surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> permits detection of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> at an early and curable stage, thereby potentially reducing mortality from oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>